Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5288693
Max Phase: Preclinical
Molecular Formula: C33H50Br2N7O4+
Molecular Weight: 768.62
Associated Items:
ID: ALA5288693
Max Phase: Preclinical
Molecular Formula: C33H50Br2N7O4+
Molecular Weight: 768.62
Associated Items:
Canonical SMILES: COc1c(Br)cc(C[C@H](NC(=O)CCCCC[N+](C)(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCc2ccccc2)cc1Br
Standard InChI: InChI=1S/C33H49Br2N7O4/c1-42(2,3)19-10-6-9-15-29(43)40-28(22-24-20-25(34)30(46-4)26(35)21-24)32(45)41-27(14-11-17-39-33(36)37)31(44)38-18-16-23-12-7-5-8-13-23/h5,7-8,12-13,20-21,27-28H,6,9-11,14-19,22H2,1-4H3,(H6-,36,37,38,39,40,41,43,44,45)/p+1/t27-,28-/m0/s1
Standard InChI Key: SXWPUSFJYJWBOB-NSOVKSMOSA-O
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 768.62 | Molecular Weight (Monoisotopic): 766.2286 | AlogP: 3.62 | #Rotatable Bonds: 20 |
Polar Surface Area: 158.43 | Molecular Species: BASE | HBA: 5 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.80 | CX Basic pKa: 11.60 | CX LogP: 1.06 | CX LogD: -3.01 |
Aromatic Rings: 2 | Heavy Atoms: 46 | QED Weighted: 0.05 | Np Likeness Score: 0.23 |
1. Craig AJ, Ermolovich Y, Cameron A, Rodler A, Wang H, Hawkes JA, Hubert M, Björkling F, Molchanova N, Brimble MA, Moodie LWK, Svenson J.. (2023) Antimicrobial Peptides Incorporating Halogenated Marine-Derived Amino Acid Substituents., 14 (6): [PMID:37312845] [10.1021/acsmedchemlett.3c00093] |
Source(1):